Clinical Trial

A Phase 2 in Adult Subjects With Hereditary Angioedema

Study acronym: HAE
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
A Phase 2 in Adult Subjects with Hereditary Angioedema
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-02-25; most recent amendment 2026-04-16.
Status change: Recruiting → Active, Not Recruiting 2026-03-09
Status change: Not Yet Recruiting → Recruiting 2025-06-25
Trial Details
NCT Number NCT06846398
Lead Sponsor Shanghai Argo Biopharmaceutical Co., Ltd.
Conditions Hereditary Angioedema (HAE)
Enrollment 25 participants
Start Date 2025-02-28
Primary Completion 2026-06-30 (estimated)
Study Completion 2028-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-17